Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-003504

Director acquired 428 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2022-01-04 Grant or award +428 $31.58 $13,516 11,380 D
Loading xslF345X03/doc4.xml…